Two-Drug combo tested in advanced head & neck cancer trial
NCT ID NCT05668949
Summary
This study aimed to test the safety and effectiveness of combining two drugs, TTI-101 and pembrolizumab, for adults with advanced head and neck cancer that had returned or spread. The goal was to see if this combination could help control the cancer better than standard treatments. The trial was withdrawn by the sponsor before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.